The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
EAACI Biologicals Guidelines—Recommendations for severe asthma
Open accessAbstract
Severe asthma imposes a significant burden on patients, families and healthcare systems. Management is difficult, due to disease heterogeneity, co‐morbidities, complexity in care pathways and differences between national or regional healthcare systems. Better understanding of the mechanisms has enabled a stratified approach to the management of severe asthma, supporting the use of targeted treatments with biologicals. However, there are still many issues that require further clarification. These include selection of a certain biological (as they all target overlapping disease phenotypes), the definition of response, strategies to enhance the responder rate, the duration of treatment and its regimen (in the clinic or home‐based) and its cost‐effectiveness. The EAACI Guidelines on the use of biologicals in severe asthma follow the GRADE approach in formulating recommendations for each biological and each outcome. In addition, a management algorithm for the use of biologicals in the clinic is proposed, together with future approaches and research priorities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Chung, K. F., Wenzel, S. E., Brozek, J. L., Bush, A., Castro, M., Sterk, P. J., Adcock, I. M., Bateman, E. D., Bel, E. H., Bleecker, E. R., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00202013 · Cited by 3,926
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Dweik, R. A., Boggs, P. B., Erzurum, S. C., Irvin, C. G., Leigh, M. W., Lundberg, J. O., Olin, A.-C., Plummer, A. L., & Taylor, D. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.9120-11st · Cited by 2,539
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Ortega, H. G., Liu, M. C., Pavord, I. D., Brusselle, G. G., FitzGerald, J. M., Chetta, A., Humbert, M., Katz, L. E., Keene, O. N., Yancey, S. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403290 · Cited by 2,322
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Moore, W. C., Meyers, D. A., Wenzel, S. E., Teague, W. G., Li, H., Li, X., D'Agostino, R., Castro, M., Curran-Everett, D., Fitzpatrick, A. M., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200906-0896oc · Cited by 2,129
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Castro, M., Corren, J., Pavord, I. D., Maspero, J., Wenzel, S., Rabe, K. F., Busse, W. W., Ford, L., Sher, L., FitzGerald, J. M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804092 · Cited by 1,986
Self-citationOral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Bachert, C., Han, J. K., Desrosiers, M., Hellings, P. W., Amin, N., Lee, S. E., Mullol, J., Greos, L. S., Bosso, J. V., Laidlaw, T. M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31881-1 · Cited by 1,563
Self-citationBleecker, E. R., FitzGerald, J. M., Chanez, P., Papi, A., Weinstein, S. F., Barker, P., Sproule, S., Gilmartin, G., Aurivillius, M., Werkström, V., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31324-1 · Cited by 1,406
Self-citationFitzGerald, J. M., Bleecker, E. R., Nair, P., Korn, S., Ohta, K., Lommatzsch, M., Ferguson, G. T., Busse, W. W., Barker, P., Sproule, S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31322-8 · Cited by 1,397
Self-citationEfficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
Rabe, K. F., Nair, P., Brusselle, G., Maspero, J. F., Castro, M., Sher, L., Zhu, H., Hamilton, J. D., Swanson, B. N., Khan, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804093 · Cited by 1,184
Self-citationCastro, M., Zangrilli, J., Wechsler, M. E., Bateman, E. D., Brusselle, G. G., Bardin, P., Murphy, K., Maspero, J. F., O'Brien, C., & Korn, S. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00042-9 · Cited by 1,182
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160
Self-citationHumbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J., Beeh, K. ‐., Ramos, S., Canonica, G. W., Hedgecock, S., et al. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00772.x · Cited by 1,123
Self-citationOral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
Nair, P., Wenzel, S., Rabe, K. F., Bourdin, A., Lugogo, N. L., Kuna, P., Barker, P., Sproule, S., Ponnarambil, S., & Goldman, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703501 · Cited by 1,044
Self-citationEndotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Anderson, G. P. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61452-x · Cited by 999
Tezepelumab in Adults with Uncontrolled Asthma
Corren, J., Parnes, J. R., Wang, L., Mo, M., Roseti, S. L., Griffiths, J. M., & van der Merwe, R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704064 · Cited by 965
Self-citationJuniper, E. F., Svensson, K., Mörk, A.-C., & Ståhl, E. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.008 · Cited by 929
Exploring the Effects of Omalizumab in Allergic Asthma: An Analysis of Biomarkers in the EXTRA Study
Hanania, N. A., Wenzel, S., Rosén, K., Hsieh, H.-J., Mosesova, S., Choy, D. F., Lal, P., Arron, J. R., Harris, J. M., & Busse, W. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1414oc · Cited by 901
Self-citationWenzel, S., Castro, M., Corren, J., Maspero, J., Wang, L., Zhang, B., Pirozzi, G., Sutherland, E. R., Evans, R. R., Joish, V. N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30307-5 · Cited by 889
Self-citationRandomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children
Busse, W. W., Morgan, W. J., Gergen, P. J., Mitchell, H. E., Gern, J. E., Liu, A. H., Gruchalla, R. S., Kattan, M., Teach, S. J., Pongracic, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009705 · Cited by 884
Self-citationThe prevalence of severe refractory asthma
Hekking, P.-P. W., Wener, R. R., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 813
Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study
Castro, M., Mathur, S., Hargreave, F., Boulet, L.-P., Xie, F., Young, J., Wilkins, H. J., Henkel, T., & Nair, P. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0396oc · Cited by 716
Self-citationTuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes
Junttila, I. S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00888 · Cited by 684
Gibson, P. G., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., Peters, M. J., Marks, G. B., Baraket, M., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31281-3 · Cited by 662
Djukanović, R., Wilson, S. J., Kraft, M., Jarjour, N. N., Steel, M., Chung, K. F., Bao, W., Fowler-Taylor, A., Matthews, J., Busse, W. W., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200312-1651oc · Cited by 646
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline
Holguin, F., Cardet, J. C., Chung, K. F., Diver, S., Ferreira, D. S., Fitzpatrick, A., Gaga, M., Kellermeyer, L., Khurana, S., Knight, S., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.00588-2019 · Cited by 629
Patterns of growth and decline in lung function in persistent childhood asthma
McGeachie, M. J., Yates, K. P., Zhou, X., Guo, F., Sternberg, A. L., Van Natta, M. L., Wise, R. A., Szefler, S. J., Sharma, S., Kho, A. T., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1513737 · Cited by 608
Bui, D. S., Lodge, C. J., Burgess, J. A., Lowe, A. J., Perret, J., Bui, M. Q., Bowatte, G., Gurrin, L., Johns, D. P., Thompson, B. R., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30100-0 · Cited by 602
Chupp, G. L., Bradford, E. S., Albers, F. C., Bratton, D. J., Wang-Jairaj, J., Nelsen, L. M., Trevor, J. L., Magnan, A., & ten Brinke, A. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30125-x · Cited by 599
Kolbeck, R., Kozhich, A., Koike, M., Peng, L., Andersson, C. K., Damschroder, M. M., Reed, J. L., Woods, R., Dall'Acqua, W. W., Stephens, G. L., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.04.004 · Cited by 586
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Jones, P. W. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00063702 · Cited by 585
Type 2 immunity in the skin and lungs
Akdis, C. A., Arkwright, P. D., Brüggen, M.-C., Busse, W., Gadina, M., Guttman‐Yassky, E., Kabashima, K., Mitamura, Y., Vian, L., Wu, J., et al. (2020) · Allergy · doi:10.1111/all.14318 · Cited by 560
Self-citationHanania, N. A., Alpan, O., Hamilos, D. L., Condemi, J. J., Reyes-Rivera, I., Zhu, J., Rosen, K. E., Eisner, M. D., Wong, D. A., & Busse, W. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00002 · Cited by 554
Self-citationLung-resident eosinophils represent a distinct regulatory eosinophil subset
Mesnil, C., Raulier, S., Paulissen, G., Xiao, X., Birrell, M. A., Pirottin, D., Janss, T., Starkl, P., Ramery, E., Henket, M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85664 · Cited by 554
Le Floc’h, A., Allinne, J., Nagashima, K., Scott, G., Birchard, D., Asrat, S., Bai, Y., Lim, W. K., Martin, J., Huang, T., et al. (2020) · Allergy · doi:10.1111/all.14151 · Cited by 545
Self-citationTeach, S. J., Gill, M. A., Togias, A., Sorkness, C. A., Arbes, S. J., Calatroni, A., Wildfire, J. J., Gergen, P. J., Cohen, R. T., Pongracic, J. A., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.09.008 · Cited by 537
Self-citationEffects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Laviolette, M., Gossage, D. L., Gauvreau, G., Leigh, R., Olivenstein, R., Katial, R., Busse, W. W., Wenzel, S., Wu, Y., Datta, V., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.020 · Cited by 511
IL-4 and IL-13 signaling in allergic airway disease
Gour, N., & Wills-Karp, M. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.014 · Cited by 490
Immunologic mechanisms in asthma
Boonpiyathad, T., Sözener, Z. C., Satitsuksanoa, P., & Akdis, C. A. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101333 · Cited by 489
Self-citationSmith, S. G., Chen, R., Kjarsgaard, M., Huang, C., Oliveria, J.-P., O'Byrne, P. M., Gauvreau, G. M., Boulet, L.-P., Lemiere, C., Martin, J., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.05.037 · Cited by 459
Self-citationChen, F., Liu, Z., Wu, W., Rozo, C., Bowdridge, S., Millman, A., Van Rooijen, N., Urban, J. F., Wynn, T. A., & Gause, W. C. (2012) · Nature Medicine · doi:10.1038/nm.2628 · Cited by 449
An expert consensus framework for asthma remission as a treatment goal
Menzies-Gow, A., Bafadhel, M., Busse, W. W., Casale, T. B., Kocks, J. W. H., Pavord, I. D., Szefler, S. J., Woodruff, P. G., de Giorgio-Miller, A., Trudo, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.12.006 · Cited by 434
Self-citationReslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels
Bjermer, L., Lemiere, C., Maspero, J., Weiss, S., Zangrilli, J., & Germinaro, M. (2016) · Chest · doi:10.1016/j.chest.2016.03.032 · Cited by 426
Agache, I., Beltran, J., Akdis, C., Akdis, M., Canelo‐Aybar, C., Canonica, G. W., Casale, T., Chivato, T., Corren, J., Del Giacco, S., et al. (2020) · Allergy · doi:10.1111/all.14221 · Cited by 408
Self-citationVignola, A. M., Humbert, M., Bousquet, J., Boulet, L., Hedgecock, S., Blogg, M., Fox, H., & Surrey, K. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00550.x · Cited by 405
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma
Corren, J., Weinstein, S., Janka, L., Zangrilli, J., & Garin, M. (2016) · Chest · doi:10.1016/j.chest.2016.03.018 · Cited by 388
Self-citationLanier, B., Bridges, T., Kulus, M., Taylor, A. F., Berhane, I., & Vidaurre, C. F. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.021 · Cited by 360
Untangling asthma phenotypes and endotypes
Agache, I., Akdis, C., Jutel, M., & Virchow, J. C. (2012) · Allergy · doi:10.1111/j.1398-9995.2012.02832.x · Cited by 345
Self-citationEAACI Guidelines on Allergen Immunotherapy: House dust mite‐driven allergic asthma
Agache, I., Lau, S., Akdis, C. A., Smolinska, S., Bonini, M., Cavkaytar, O., Flood, B., Gajdanowicz, P., Izuhara, K., Kalayci, O., et al. (2019) · Allergy · doi:10.1111/all.13749 · Cited by 319
Self-citationPediatric severe asthma is characterized by eosinophilia and remodeling without TH2 cytokines
Bossley, C. J., Fleming, L., Gupta, A., Regamey, N., Frith, J., Oates, T., Tsartsali, L., Lloyd, C. M., Bush, A., & Saglani, S. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.01.059 · Cited by 316
Agache, I., & Akdis, C. A. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124611 · Cited by 313
Self-citationGill, M. A., Bajwa, G., George, T. A., Dong, C. C., Dougherty, I. I., Jiang, N., Gan, V. N., & Gruchalla, R. S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901194 · Cited by 310
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age
Teague, W. G., Phillips, B. R., Fahy, J. V., Wenzel, S. E., Fitzpatrick, A. M., Moore, W. C., Hastie, A. T., Bleecker, E. R., Meyers, D. A., Peters, S. P., et al. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2017.05.032 · Cited by 280
Ayres, J. G., Higgins, B., Chilvers, E. R., Ayre, G., Blogg, M., & Fox, H. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00533.x · Cited by 279
Casale, T. B., Luskin, A. T., Busse, W., Zeiger, R. S., Trzaskoma, B., Yang, M., Griffin, N. M., & Chipps, B. E. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.04.043 · Cited by 276
Self-citationWhat are minimal important changes for asthma measures in a clinical trial?
Santanello, N. C., Zhang, J., Seidenberg, B., Reiss, T. F., & Barber, B. L. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14a06.x · Cited by 275
IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma
Kabesch, M., Schedel, M., Carr, D., Woitsch, B., Fritzsch, C., Weiland, S. K., & von Mutius, E. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.024 · Cited by 274
Innate and adaptive type 2 immunity in lung allergic inflammation
Kubo, M. (2017) · Immunological Reviews · doi:10.1111/imr.12557 · Cited by 269
Mechanisms and therapeutic strategies for non‐T2 asthma
Sze, E., Bhalla, A., & Nair, P. (2020) · Allergy · doi:10.1111/all.13985 · Cited by 259
Self-citationIL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
Saglani, S., Lui, S., Ullmann, N., Campbell, G. A., Sherburn, R. T., Mathie, S. A., Denney, L., Bossley, C. J., Oates, T., Walker, S. A., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.012 · Cited by 258
Fleming, L., Murray, C., Bansal, A. T., Hashimoto, S., Bisgaard, H., Bush, A., Frey, U., Hedlin, G., Singer, F., van Aalderen, W. M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00780-2015 · Cited by 232
The expanding role(s) of eosinophils in health and disease
Jacobsen, E. A., Helmers, R. A., Lee, J. J., & Lee, N. A. (2012) · Blood · doi:10.1182/blood-2012-06-330845 · Cited by 219
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patients
Michalovich, D., Rodriguez-Perez, N., Smolinska, S., Pirozynski, M., Mayhew, D., Uddin, S., Van Horn, S., Sokolowska, M., Altunbulakli, C., Eljaszewicz, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13751-9 · Cited by 213
Self-citationThe Regulatory Function of Eosinophils
Wen, T., & Rothenberg, M. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0020-2015 · Cited by 208
Immunity to Helminths: Resistance, Regulation, and Susceptibility to Gastrointestinal Nematodes
Grencis, R. K. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120218 · Cited by 207
Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma
Corren, J., Castro, M., O'Riordan, T., Hanania, N. A., Pavord, I. D., Quirce, S., Chipps, B. E., Wenzel, S. E., Thangavelu, K., Rice, M. S., et al. (2020) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2019.08.050 · Cited by 203
Self-citationToward clinically applicable biomarkers for asthma: An EAACI position paper
Diamant, Z., Vijverberg, S., Alving, K., Bakirtas, A., Bjermer, L., Custovic, A., Dahlen, S., Gaga, M., Gerth van Wijk, R., Del Giacco, S., et al. (2019) · Allergy · doi:10.1111/all.13806 · Cited by 201
Self-citationAgache, I., & Akdis, C. A. (2016) · Allergology International · doi:10.1016/j.alit.2016.04.011 · Cited by 195
Self-citationEnhanced plasmacytoid dendritic cell antiviral responses after omalizumab
Gill, M. A., Liu, A. H., Calatroni, A., Krouse, R. Z., Shao, B., Schiltz, A., Gern, J. E., Togias, A., & Busse, W. W. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.035 · Cited by 195
Self-citationLocal amplifiers of IL-4Rα–mediated macrophage activation promote repair in lung and liver
Minutti, C. M., Jackson-Jones, L. H., García-Fojeda, B., Knipper, J. A., Sutherland, T. E., Logan, N., Ringqvist, E., Guillamat-Prats, R., Ferenbach, D. A., Artigas, A., et al. (2017) · Science · doi:10.1126/science.aaj2067 · Cited by 194
Ravin, K. A., & Loy, M. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8525-4 · Cited by 193
Homeostatic Eosinophils: Characteristics and Functions
Marichal, T., Mesnil, C., & Bureau, F. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00101 · Cited by 191
Li, Y., Wang, W., Lv, Z., Li, Y., Chen, Y., Huang, K., Corrigan, C. J., & Ying, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701455 · Cited by 187
Omalizumab is effective in the long-term control of severe allergic asthma
Lanier, B. Q., Corren, J., Lumry, W., Liu, J., Fowler-Taylor, A., & Gupta, N. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62170-9 · Cited by 183
Self-citationPharmacology and Therapeutics of Bronchodilators Revisited
Matera, M. G., Page, C. P., Calzetta, L., Rogliani, P., & Cazzola, M. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018150 · Cited by 172
Wildfire, J. J., Gergen, P. J., Sorkness, C. A., Mitchell, H. E., Calatroni, A., Kattan, M., Szefler, S. J., Teach, S. J., Bloomberg, G. R., Wood, R. A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.12.962 · Cited by 171
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
Marone, G., Granata, F., Pucino, V., Pecoraro, A., Heffler, E., Loffredo, S., Scadding, G. W., & Varricchi, G. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01387 · Cited by 171
Noga, O., Hanf, G., Brachmann, I., Klucken, A. C., Kleine-Tebbe, J., Rosseau, S., Kunkel, G., Suttorp, N., & Seybold, J. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.028 · Cited by 170
Hinks, T. S. C., Brown, T., Lau, L. C. K., Rupani, H., Barber, C., Elliott, S., Ward, J. A., Ono, J., Ohta, S., Izuhara, K., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.11.020 · Cited by 170
Venter, C., Meyer, R. W., Nwaru, B. I., Roduit, C., Untersmayr, E., Adel‐Patient, K., Agache, I., Agostoni, C., Akdis, C. A., Bischoff, S. C., et al. (2019) · Allergy · doi:10.1111/all.13764 · Cited by 164
Self-citationComorbid “treatable traits” in difficult asthma: Current evidence and clinical evaluation
Tay, T. R., & Hew, M. J. (2017) · Allergy · doi:10.1111/all.13370 · Cited by 162
The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
Chapman, K. R., Albers, F. C., Chipps, B., Muñoz, X., Devouassoux, G., Bergna, M., Galkin, D., Azmi, J., Mouneimne, D., Price, R. G., et al. (2019) · Allergy · doi:10.1111/all.13850 · Cited by 162
Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma
Casale, T. B., Chipps, B. E., Rosén, K., Trzaskoma, B., Haselkorn, T., Omachi, T. A., Greenberg, S., & Hanania, N. A. (2018) · Allergy · doi:10.1111/all.13302 · Cited by 158
Self-citationType 2 innate lymphoid cells in induced sputum from children with severe asthma
Nagakumar, P., Denney, L., Fleming, L., Bush, A., Lloyd, C. M., & Saglani, S. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.06.038 · Cited by 149
Agache, I. O., Rocha, C. A., Beltran, J., Song, Y., Posso, M., Solà, I., Alonso‐Coello, P., Akdiş, C. A., Akdiş, M., Canonica, G. W., et al. (2020) · Allergy · doi:10.1111/all.14235 · Cited by 146
Self-citationPerspectives in allergen immunotherapy: 2019 and beyond
Pfaar, O., Agache, I. O., Frederic de, B. L. A. Y., Bonini, S., Chaker, A. M., Durham, S. R., Gawlik, R., Hellings, P. W., Jutel, M., Kleine‐Tebbe, J., et al. (2019) · Allergy · doi:10.1111/all.14077 · Cited by 142
Self-citationTeufelberger, A. R., Nordengrün, M., Braun, H., Maes, T., Grove, K. C. D., Holtappels, G., O'Brien, C., Provoost, S., Hammad, H., Gonçalves, A. C., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.004 · Cited by 139
Diagnosis and management of eosinophilic asthma: a US perspective
Doherty, T. A., & Walford, H. (2014) · Journal of Asthma and Allergy · doi:10.2147/jaa.s39119 · Cited by 138
Wang, W., Li, Y., Lv, Z., Chen, Y., Li, Y., Huang, K., Corrigan, C. J., & Ying, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800709 · Cited by 138
Effect of omalizumab on peripheral blood eosinophilia in allergic asthma
Massanari, M. J., Holgate, S. T., Busse, W. W., Jimenez, P. A., Kianifard, F., & Zeldin, R. K. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.09.011 · Cited by 132
Sputum autoantibodies in patients with severe eosinophilic asthma
Mukherjee, M., Bulir, D. C., Radford, K., Kjarsgaard, M., Huang, C., Jacobsen, E. A., Ochkur, S. I., Catuneanu, A., Lamothe-Kipnes, H., Mahony, J. B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.033 · Cited by 128
Self-citationCost-effectiveness and comparative effectiveness of biologic therapy for asthma
Anderson, W. C., & Szefler, S. J. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.01.018 · Cited by 128
Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response
Crawford, G., Hayes, M. D., Seoane, R. C., Ward, S., Dalessandri, T., Lai, C., Healy, E., Kipling, D., Proby, C. M., Moyes, C., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0161-8 · Cited by 123
Recent developments and highlights in mechanisms of allergic diseases: Microbiome
Lunjani, N., Satitsuksanoa, P., Łukasik, Z. M., Sokołowska, M., Eiwegger, T., & O’Mahony, L. (2018) · Allergy · doi:10.1111/all.13634 · Cited by 120
Self-citationCanonica, G. W., Colombo, G. L., Bruno, G. M., Matteo, S. D., Martinotti, C., Blasi, F., Bucca, C. B., Crimi, N., Paggiaro, P., Pelaia, G., et al. (2019) · World Allergy Organization Journal · doi:10.1016/j.waojou.2018.12.001 · Cited by 120
Self-citationEAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders
Boyman, O., Kaegi, C., Akdiş, M., Bavbek, S., Bossios, A., Chatzipetrou, A., Eiwegger, T., Firinu, D., Harr, T., Knol, E. F., et al. (2015) · Allergy · doi:10.1111/all.12616 · Cited by 118
Self-citationDistinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents
Pongracic, J. A., Krouse, R. Z., Babineau, D. C., Zoratti, E. M., Cohen, R. T., Wood, R. A., Hershey, G. K. K., Kercsmar, C. M., Gruchalla, R. S., Kattan, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.059 · Cited by 117
Self-citationStaphylococcus aureusand its IgE-inducing enterotoxins in asthma: current knowledge
Bachert, C., Humbert, M. J. C., Hanania, N. A., Zhang, N., Holgate, S. T., Buhl, R., & Bröker, B. M. (2020) · European Respiratory Journal · doi:10.1183/13993003.01592-2019 · Cited by 117
Self-citationChipps, B. E., Newbold, P., Hirsch, I., Trudo, F. J., & Goldman, M. A. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.01.030 · Cited by 116
Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti‐IgE treatment
van Rensen, E. L. J., Evertse, C. E., van Schadewijk, W. A. A. M., van Wijngaarden, S., Ayre, G., Mauad, T., Hiemstra, P. S., Sterk, P. J., & Rabe, K. F. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01881.x · Cited by 114
Chen, S. H., Golam, S. M., Myers, J. A., Bly, C. A., Smolen, H. J., & Xu, X. P. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1505352 · Cited by 111
Intraepithelial neutrophils in pediatric severe asthma are associated with better lung function
Andersson, C. K., Adams, A., Nagakumar, P., Bossley, C. J., Gupta, A. K., Vries, D. D., Adnan, A., Bush, A., Saglani, S., & Lloyd, C. M. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.022 · Cited by 108
Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry
de Llano, L. P., Vennera, M. D. C., Gutiérrez, F. J. Á., Gallardo, J. F. M., Borderías, L., Pellicer, C., González, H., Blanco, J. A. G., Martínez‐Moragón, E., Sabadell, C., et al. (2013) · Journal of Asthma · doi:10.3109/02770903.2012.757780 · Cited by 107
Nonadherence in the era of severe asthma biologics and thermoplasty
Lee, J., Tay, T. R., Radhakrishna, N., Hore‐Lacy, F., Mackay, A., Hoy, R. F., Dabscheck, E. J., O’Hehir, R. E., & Hew, M. J. (2018) · European Respiratory Journal · doi:10.1183/13993003.01836-2017 · Cited by 107
Different endotypes and phenotypes drive the heterogeneity in severe asthma
McDowell, P. J., & Heaney, L. G. (2019) · Allergy · doi:10.1111/all.13966 · Cited by 104
Dupilumab: Basic aspects and applications to allergic diseases
Matsunaga, K., Katoh, N., Fujieda, S., Izuhara, K., & Oishi, K. (2020) · Allergology International · doi:10.1016/j.alit.2020.01.002 · Cited by 104
Precision medicine for the discovery of treatable mechanisms in severe asthma
Chung, K. F., & Adcock, I. M. (2019) · Allergy · doi:10.1111/all.13771 · Cited by 100
Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils
Heeb, L. E. M., Egholm, C., & Boyman, O. (2020) · Genes and Immunity · doi:10.1038/s41435-020-0095-7 · Cited by 100
AllergoOncology – the impact of allergy in oncology: EAACI position paper
Jensen‐Jarolim, E., Bax, H. J., Bianchini, R., Capron, M., Corrigan, C. J., Castells, M., Dombrowicz, D., Daniels‐Wells, T. R., Fazekas, J., Fiebiger, E., et al. (2016) · Allergy · doi:10.1111/all.13119 · Cited by 99
The emerging roles of eosinophils in mucosal homeostasis
Shah, K., Ignácio, A., McCoy, K. D., & Harris, N. L. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0281-y · Cited by 99
Kabata, H., Flamar, A.-L., Mahlakõiv, T., Moriyama, S., Rodewald, H.-R., Ziegler, S. F., & Artis, D. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0266-x · Cited by 98
Adherence to inhaled corticosteroids and clinical outcomes in mepolizumab therapy for severe asthma
d’Ancona, G., Kavanagh, J. E., Roxas, C., Green, L., FERNANDES, M. R., Thomson, L., Dhariwal, J., Nanzer, A. M., Jackson, D. J., & Kent, B. D. (2020) · European Respiratory Journal · doi:10.1183/13993003.02259-2019 · Cited by 96
Agache, I. O., Song, Y., Rocha, C., Beltran, J., Posso, M., Steiner, C., Alonso‐Coello, P., Akdiş, C. A., Akdiş, M., Canonica, G. W., et al. (2020) · Allergy · doi:10.1111/all.14268 · Cited by 92
Self-citationCare pathways for the selection of a biologic in severe asthma
Bousquet, J. J., Brusselle, G., Buhl, R., Busse, W. W., Cruz, Á. A., Djukanović, R., Domingo, C., Hanania, N. A., Humbert, M. J. C., Gow, A. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01782-2017 · Cited by 91
Self-citationOmalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma
Chanez, P., Contin‐Bordes, C., Garcia, G., Verkindre, C., Didier, A. P., Frederic de, B. L. A. Y., de Lara, M. T., Blanco, P., Moreau, J., Robinson, P., et al. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.07.011 · Cited by 88
Rup, B., Pallardy, M. J., Sikkema, D., Albert, T., Allez, M., Broët, P., Carini, C., Creeke, P. I., Davidson, J. E., de Vries, N., et al. (2015) · Clinical & Experimental Immunology · doi:10.1111/cei.12652 · Cited by 88
The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside
Agache, I., Sugita, K., Morita, H., Akdis, M., & Akdis, C. A. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0529-x · Cited by 86
Self-citationSevere asthma in children—a review of definitions, epidemiology, and treatment options in 2019
Ahmed, H., & Turner, S. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24317 · Cited by 84
Severe asthma phenotypes and endotypes
Agache, I. O. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.101301 · Cited by 84
Self-citationAnaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
Lieberman, P. L., Jones, I., Rajwanshi, R., Rosén, K. E., & Umetsu, D. T. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.07.013 · Cited by 81
Pathways through which asthma risk factors contribute to asthma severity in inner-city children
Liu, A. H., Babineau, D. C., Krouse, R. Z., Zoratti, E. M., Pongracic, J. A., O’Connor, G. T., Wood, R. A., Hershey, G. K. K., Kercsmar, C. M., Gruchalla, R. S., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.060 · Cited by 80
Self-citationPellizzari, G., Hoskin, C., Crescioli, S., Mele, S., Gotovina, J., Chiaruttini, G., Bianchini, R., Ilieva, K., Bax, H. J., Papa, S., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.080 · Cited by 77
dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies
Palomares, Ó., Sánchez‐Ramón, S., Davila, I. J., Prieto, L. M., de Llano, L. P., Lleonart, M., Domingo, C., & Nieto, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061328 · Cited by 73
Mechanisms of Allergen-Specific Immunotherapy and Novel Ways for Vaccine Development
Jutel, M., van de Veen, W., Agache, I. O., Azkur, K. A., Akdis, M., & Akdiş, C. A. (2013) · Allergology International · doi:10.2332/allergolint.13-rai-0608 · Cited by 70
Self-citationAgache, I. O., Strasser, D. S., Klenk, A., Agache, C., Farine, H., Ciobanu, C., Groenen, P. M. A., & Akdiş, C. A. (2016) · Allergy · doi:10.1111/all.12906 · Cited by 70
Self-citationThe cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis
Barry, L. E., Sweeney, J., O’Neill, C., Price, D. B., & Heaney, L. G. (2017) · Respiratory Research · doi:10.1186/s12931-017-0614-x · Cited by 70
Benralizumab: A New Approach for the Treatment of Severe Eosinophilic Asthma
Davila, I. J., Benítez, F. M., & Quirce, S. (2019) · Journal of Investigational Allergology and Clinical Immunology · doi:10.18176/jiaci.0385 · Cited by 69
Self-citationWang, F., Liu, T., Zhu, L., Li, S., & Mao, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166833 · Cited by 68
The use of biologics for immune modulation in allergic disease
van de Veen, W., & Akdiş, M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124607 · Cited by 66
Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity
Jiménez‐Saiz, R., Anipindi, V. C., Galipeau, H. J., Ellenbogen, Y., Chaudhary, R., Koenig, J. F. E., Gordon, M. E., Walker, T. D., Mandur, T. S., Abed, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00155 · Cited by 63
Self-citationFrom phenotypes to endotypes to asthma treatment
Agache, I. O. (2013) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32836093dd · Cited by 62
Self-citationThe Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
BOURDIN, A. A., Fabry-Vendrand, C., Ostinelli, J., Ait-Yahia, M., Darnal, E., Bouée, S., Laurendeau, C., Bureau, I., Gourmelen, J., & CHOUAID, C. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.12.029 · Cited by 62
A Complement–IL-4 Regulatory Circuit Controls Liver Regeneration
DeAngelis, R. A., Markiewski, M. M., Kourtzelis, I., Rafail, S., Syriga, M., Sandor, A., Maurya, M. R., Gupta, S., Subramaniam, S., & Lambris, J. D. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101925 · Cited by 60
Agache, I. O., Annesi‐Maesano, I., Bonertz, A., Branca, F., Cant, A. J., Fras, Z., Ingenrieth, F., Namazova-Baranova, L. S., Odemyr, M., Spanevello, A., et al. (2019) · Allergy · doi:10.1111/all.13856 · Cited by 60
Self-citationAltered Epithelial Gene Expression in Peripheral Airways of Severe Asthma
Singhania, A., Rupani, H., Jayasekera, N. P., Lumb, S., Hales, P., Gozzard, N., Davies, D. E., Woelk, C. H., & Howarth, P. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168680 · Cited by 59
Shaker, M. S., Briggs, A., Dbouk, A., Dutille, E. K., Oppenheimer, J. J., & Greenhawt, M. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.09.037 · Cited by 58
International Severe Asthma Registry
Canonica, G. W., Alacqua, M., Altraja, A., Backer, V., Bel, E. H., Bjermer, L. H., Björnsdóttir, U. S., BOURDIN, A. A., Brusselle, G., Christoff, G., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.10.051 · Cited by 58
Self-citationVenkataramani, S., Low, S. H. H., Weigle, B., Dutcher, D. L., Jerath, K., Menzenski, M., Frego, L., Truncali, K., Gupta, P., Kroe‐Barrett, R., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.064 · Cited by 56
SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
on Behalf of, S. A. N. I., Senna, G., Guerriero, M., Paggiaro, P., Blasi, F., Caminati, M., Heffler, E. M., Latorre, M., & Canonica, G. W. (2017) · Clinical and Molecular Allergy · doi:10.1186/s12948-017-0065-4 · Cited by 55
Self-citationMaggi, L., Rossettini, B., Montaini, G., Matucci, A., Vultaggio, A., Mazzoni, A., Palterer, B., Parronchi, P., Maggi, E., Liotta, F., et al. (2018) · European Journal of Immunology · doi:10.1002/eji.201847668 · Cited by 55
Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
Castro, M., Rabe, K. F., Corren, J., Pavord, I. D., Katelaris, C. H., Tohda, Y., Zhang, B., Rice, M. S., Maroni, J. M., Rowe, P., et al. (2020) · ERJ Open Research · doi:10.1183/23120541.00204-2019 · Cited by 54
Self-citationAsthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?
Agache, I. O., & Rogozea, L. M. (2017) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2017.9.6.466 · Cited by 49
Self-citationRoth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2018) · Allergy · doi:10.1111/all.13642 · Cited by 49
Panettieri, R. A., Welte, T., Shenoy, K. V., Korn, S., Jandl, M., Kerwin, E., Feijoo, R., Barker, P. N., Olsson, R. F., & Martin, U. J. (2020) · Journal of Asthma and Allergy · doi:10.2147/jaa.s240044 · Cited by 49
Takaku, Y., Soma, T., Nishihara, F., Nakagome, K., Kobayashi, T., Hagiwara, K., Kanazawa, M., & Nagata, M. (2013) · International Archives of Allergy and Immunology · doi:10.1159/000350852 · Cited by 48
Potential Role of the Lung Microbiome in Shaping Asthma Phenotypes
Chung, K. F. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201702-138aw · Cited by 48
The effects of omalizumab on IgE-induced cytokine synthesis by asthmatic airway smooth muscle cells
Roth, M., & Tamm, M. (2010) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2009.11.022 · Cited by 47
Khindri, S. K., Cahn, A. P., Begg, M., Montembault, M., Leemereise, C., Cui, Y., Hogg, A., Wajdner, H., Yang, S., Robertson, J., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.249516 · Cited by 43
Management of severe asthma: targeting the airways, comorbidities and risk factors
Gibson, P. G., & McDonald, V. M. (2017) · Internal Medicine Journal · doi:10.1111/imj.13441 · Cited by 41
Asthma across the lifespan: Time for a paradigm shift
Szefler, S. J. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.03.010 · Cited by 40
Endotypes of severe allergic asthma patients who clinically benefit from anti‐IgE therapy
Huang, Y., Weng, C., Lee, M.-J., Lin, S., Wang, C., & Kuo, H. (2018) · Clinical & Experimental Allergy · doi:10.1111/cea.13248 · Cited by 40
Current State and Future of Biologic Therapies in the Treatment of Asthma in Children
Abrams, E. M., Becker, A. B., & Szefler, S. J. (2018) · Pediatric Allergy Immunology and Pulmonology · doi:10.1089/ped.2018.0901 · Cited by 39
The evolving algorithm of biological selection in severe asthma
Papadopoulos, N. G., Barnes, P. J., Canonica, G. W., Gaga, M., Heaney, L. G., Menzies-Gow, A. N., Kritikos, V. S., & Fitzgerald, M. (2020) · Allergy · doi:10.1111/all.14256 · Cited by 39
Self-citationIgE deficiency and prior diagnosis of malignancy
Ferastraoaru, D. E., & Rosenstreich, D. L. (2018) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2018.07.036 · Cited by 38
Trends in Omalizumab Utilization for Asthma: Evidence of Suboptimal Patient Selection
Jeffery, M. M., Shah, N. D., Karaca‐Mandic, P., Ross, J. S., & Rank, M. A. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.07.034 · Cited by 37
Mathioudakis, A. G., Čustović, A., Deschildre, A., Ducharme, F. M., Kalaycı, Ö., Murray, C. S., Garcia, A. N., Phipatanakul, W., Price, D. B., Sheikh, A., et al. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.01.059 · Cited by 37
Self-citationde Llano, L. A. P., Martínez‐Moragón, E., Plaza, V., Trisán, A., Sánchez, C. A., Callejas, F. J., Vera, E., Campos, J. G. S., Martínez‐Rivera, C., Navarrete, B. A., et al. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.03.006 · Cited by 36
Efficacy of an Inhaled IL-13 Antibody Fragment in a Model of Chronic Asthma
Lightwood, D. J., Tservistas, M., Zehentleitner, M., Sarkar, K., Turner, A. V., Bracher, M. G., Smith, B., Lamour, S., Bourne, T., Shaw, S., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2382oc · Cited by 35
Zhang, F., Han, X., Zhang, F., Ma, X., Xiang, D., Yang, X., Ou‐Yang, H., & Li, Z. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.03.005 · Cited by 34
Calbet, M., Ramis, I., Calama, E., Carreño, C., Paris, S., Maldonado, M., Orellana, A., Calaf, E., Pauta, M., Alba, J. D., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.256263 · Cited by 34
Development and initial validation of the Asthma Severity Scoring System (ASSESS)
Fitzpatrick, A. M., Szefler, S. J., Mauger, D. T., Phillips, B. R., Denlinger, L. C., Moore, W. C., Sorkness, R. L., Wenzel, S. E., Gergen, P. J., Bleecker, E. R., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.09.018 · Cited by 34
Role of IL-13 Genetic Variants in Signalling of Asthma
Alasandagutti, M. L., Ansari, M. S. S., Sagurthi, S. R., Valluri, V., & Gaddam, S. (2017) · Inflammation · doi:10.1007/s10753-016-0503-3 · Cited by 32
Critical Points on the Use of Biologicals in Allergic Diseases and Asthma
Agache, I. O., Cojanu, C., Laculiceanu, A. G., & Rogozea, L. M. (2019) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2020.12.1.24 · Cited by 29
Self-citationChildhood severe asthma: New insights on remodelling and biomarkers
Saglani, S. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.06.001 · Cited by 23
Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach
Singh, H., Peters, J. I., Kaur, Y., Maselli, D. J., & Diaz, J. D. (2019) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2019.07.026 · Cited by 22
Omalizumab: An update on efficacy and safety in moderate-to-severe allergic asthma
Chipps, B. E., Figliomeni, M., & Spector, S. L. (2012) · Allergy and Asthma Proceedings · doi:10.2500/aap.2012.33.3599 · Cited by 21
Ramirez-Carrozzi, V. R., Sambandam, A., Zhou, M., Yan, D., Kang, J., Wu, X., Suto, E., Baca, M., Austin, C. D., Xu, M., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.026 · Cited by 20
Efthimiou, J., Poll, C. T., & Barnes, P. J. (2019) · European Respiratory Journal · doi:10.1183/13993003.02390-2018 · Cited by 14
Cusack, R. P., Sahadevan, A., & Lane, S. J. (2016) · QJM · doi:10.1093/qjmed/hcw027 · Cited by 12
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma
Matera, M. G., Rogliani, P., Calzetta, L., & Cazzola, M. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1421170 · Cited by 12
Severe asthma in children: therapeutic considerations
Selby, L., & Saglani, S. (2019) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000521 · Cited by 12
Les patients de la cohorte IDEAL : une photographie de l’asthme sévère en France
Taillé, C., Pison, C. M., Nocent, C., Devouassoux, G., Prudhomme, A., Gruber, A., Gunsoy, N. B., & Albers, F. C. (2018) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2018.10.005 · Cited by 8
Cited by
Type 2 immunity in allergic diseases
Ogulur, I., Mitamura, Y., Yazici, D., Pat, Y., Ardicli, S., Li, M., D’Avino, P., Beha, C., Babayev, H., Zhao, B., et al. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01261-2 · Cited by 362
Self-citationAstegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial
Kelsen, S. G., Agache, I. O., Soong, W., Israel, E., Chupp, G. L., Cheung, D. S., Theess, W., Yang, X., Staton, T. L., Choy, D. F., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.03.044 · Cited by 319
Self-citationAlpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper
Fieten, K. B., Drijver‐Messelink, M. T., Cogo, A., Charpin, D., Sokolowska, M., Agache, I., Taborda‐Barata, L. M., Eguiluz‐Gracia, I., Braunstahl, G. J., Seys, S. F., et al. (2022) · Allergy · doi:10.1111/all.15242 · Cited by 45
Self-citation
Metadata
- Authors
- Agache, I., Akdis, C. A., Akdis, M., Canonica, G. W., Casale, T., Chivato, T., Corren, J., Chu, D. K., Del Giacco, S., Eiwegger, T., Flood, B., Firinu, D., Gern, J. E., Hamelmann, E., Hanania, N., Hernández‐Martín, I., Knibb, R., Mäkelä, M., Nair, P., O’Mahony, L., Papadopoulos, N. G., Papi, A., Park, H., Pérez de Llano, L., Pfaar, O., Quirce, S., Sastre, J., Shamji, M., Schwarze, J., Palomares, O., & Jutel, M.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2020-08-10
- Volume
- 76
- Issue
- 1
- Pages
- 14-44
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W3029612125
- Cited by
- 275
- References
- 176
- FWCI
- 20.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.